Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

被引:121
作者
Labidi-Galy, Sana Intidhar [1 ,2 ,3 ,4 ,5 ,6 ]
Treilleux, Isabelle [7 ]
Goddard-Leon, Sophie [7 ]
Combes, Jean-Damien [8 ]
Blay, Jean-Yves [1 ,2 ,3 ,4 ,5 ,6 ]
Ray-Coquard, Isabelle [6 ]
Caux, Christophe [1 ,2 ,3 ,4 ,5 ]
Bendriss-Vermare, Nathalie [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Lyon, Lyon, France
[2] Univ Lyon 1, ISPB, F-69365 Lyon, France
[3] INSERM, U1052, Ctr Rech Cancerol Lyon, F-69008 Lyon, France
[4] CNRS, UMR5286, Ctr Rech Cancerol Lyon, Lyon, France
[5] LabEx DEVweCAN, Lyon, France
[6] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
[7] Ctr Leon Berard, Dept Biopathol, F-69373 Lyon, France
[8] Ctr Leon Berard, Dept Biostat, F-69373 Lyon, France
关键词
plasmacytoid dendritic cell; ovarian cancer; immune tolerance; prognosis; progression-free survival; CHRONIC MYELOID-LEUKEMIA; IMATINIB;
D O I
10.4161/onci.18801
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using two different and complementary approaches (flow cytometry and immunohistochemistry) on two independent cohorts of ovarian cancer patients, we found that accumulation of plasmacytoid dendritic cells (pDC) in tumors is associated with early relapse. This deleterious effect of tumor-associated pDC was evident when they are present in cancer epithelium but not in lymphoid aggregates.
引用
收藏
页码:379 / 381
页数:3
相关论文
共 10 条
[1]   Intraperitoneal α-interferon alternating with cisplatin in residual ovarian carcinoma:: A phase II Gynecologic Oncology Group study [J].
Berek, JS ;
Markman, M ;
Blessing, JA ;
Kucera, PR ;
Nelson, BE ;
Anderson, B ;
Hanjani, P .
GYNECOLOGIC ONCOLOGY, 1999, 74 (01) :48-52
[2]   Interferons, immunity and cancer immunoediting [J].
Dunn, Gavin P. ;
Koebel, Catherine M. ;
Schreiber, Robert D. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) :836-848
[3]   Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses [J].
Golding, Amit ;
Rosen, Antony ;
Petri, Michelle ;
Akhter, Ehtisham ;
Andrade, Felipe .
IMMUNOLOGY, 2010, 131 (01) :107-117
[4]   Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer [J].
Hirsch, Ivan ;
Caux, Christophe ;
Hasan, Uzma ;
Bendriss-Vermare, Nathalie ;
Olive, Daniel .
TRENDS IN IMMUNOLOGY, 2010, 31 (10) :391-397
[5]  
Jensen T.O., 2011, Cancer
[6]   Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer [J].
Labidi-Galy, Sana Intidhar ;
Sisirak, Vanja ;
Meeus, Pierre ;
Gobert, Michael ;
Treilleux, Isabelle ;
Bajard, Agathe ;
Combes, Jean-Damien ;
Faget, Julien ;
Mithieux, Francois ;
Cassignol, Alexandre ;
Tredan, Olivier ;
Durand, Isabelle ;
Menetrier-Caux, Christine ;
Caux, Christophe ;
Blay, Jean-Yves ;
Ray-Coquard, Isabelle ;
Bendriss-Vermare, Nathalie .
CANCER RESEARCH, 2011, 71 (16) :5423-5434
[7]   Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia [J].
Mohty, M ;
Jourdan, E ;
Ben Mami, N ;
Vey, N ;
Damaj, G ;
Blaise, D ;
Isnardon, D ;
Olive, D ;
Gaugler, B .
BLOOD, 2004, 103 (12) :4666-4668
[8]   Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia. [J].
Preudhomme, Claude ;
Guilhot, Joelle ;
Nicolini, Franck Emmanuel ;
Guerci-Bresler, Agnes ;
Rigal-Huguet, Francoise ;
Maloisel, Frederic ;
Coiteux, Valerie ;
Gardembas, Martine ;
Berthou, Christian ;
Vekhoff, Anne ;
Rea, Delphine ;
Jourdan, Eric ;
Allard, Christian ;
Delmer, Alain ;
Rousselot, Philippe ;
Legros, Laurence ;
Berger, Marc ;
Corm, Selim ;
Etienne, Gabriel ;
Roche-Lestienne, Catherine ;
Eclache, Virginie ;
Mahon, Francois-Xavier ;
Guilhot, Francois .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) :2511-2521
[9]  
SISIRAK V, 2008, 10 INT S DENDR CELLS
[10]   Plasmacytoid dendritic cells and cancer [J].
Vermi, William ;
Soncini, Matias ;
Melocchi, Laura ;
Sozzani, Silvano ;
Facchetti, Fabio .
JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 90 (04) :681-690